Cargando…

Differences in Stage of Cancer at Diagnosis, Treatment, and Survival by Race and Ethnicity Among Leading Cancer Types

IMPORTANCE: Information about stage of cancer at diagnosis, use of therapy, and survival among patients from different racial/ethnic groups with 1 of the most common cancers is lacking. OBJECTIVE: To assess stage of cancer at diagnosis, use of therapy, overall survival (OS), and cancer-specific surv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Chenyue, Zhang, Chenxing, Wang, Qingliang, Li, Zhenxiang, Lin, Jiamao, Wang, Haiyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142383/ https://www.ncbi.nlm.nih.gov/pubmed/32267515 http://dx.doi.org/10.1001/jamanetworkopen.2020.2950

Ejemplares similares

Patients With BRAF-Mutant NSCLC May Not Benefit From Immune Checkpoint Inhibitors: A Population-Based Study
por: Zhang, Chenxing, et al.
Publicado: (2020)

Clinicopathological Difference and Survival Impact of Patients with c-SCLC and SCLC
por: Zhang, Chenyue, et al.
Publicado: (2021)

Surgery as a Potential Treatment Option for Patients With Stage III Small-Cell Lung Cancer: A Propensity Score Matching Analysis
por: Zhang, Chenyue, et al.
Publicado: (2019)

Molecular subtyping of small‐cell lung cancer based on mutational signatures with different genomic features and therapeutic strategies
por: Wang, Haiyong, et al.
Publicado: (2022)

Survival Outcomes by Race and Ethnicity in Veterans With Nonmetastatic Castration-Resistant Prostate Cancer
por: Rasmussen, Kelli M., et al.
Publicado: (2023)

Screening differential circular RNA expression profiles reveal that hsa_circ_0128298 is a biomarker in the diagnosis and prognosis of hepatocellular carcinoma
por: Chen, Dawei, et al.
Publicado: (2018)

A 5-Genomic Mutation Signature Can Predict the Survival for Patients With NSCLC Receiving Atezolizumab
por: Lin, Jiamao, et al.
Publicado: (2021)

Orchestrating smart therapeutics to achieve optimal treatment in small cell lung cancer: recent progress and future directions
por: Zhang, Chenyue, et al.
Publicado: (2023)

Radiotherapy may improve survival of ES-SCLC with distant metastasis only for patients with one metastatic site: A population-based study
por: Shang, Xiaoling, et al.
Publicado: (2020)

Incorporating the Number of PLN into the AJCC Stage Could Better Predict the Survival for Patients with NSCLC: A Large Population-Based Study
por: Shang, Xiaoling, et al.
Publicado: (2020)

Circular RNA hsa_circ_0078602 may have potential as a prognostic biomarker for patients with hepatocellular carcinoma
por: Kou, Peisi, et al.
Publicado: (2019)

Genomic Variations and Immune-Related Features of TMB, PD-L1 Expression and CD8(+) T Cell Infiltration in Chinese Pulmonary Sarcomatoid Carcinoma
por: Zhang, Chenyue, et al.
Publicado: (2022)

Hospitalization and Mortality Outcomes Among Childhood Cancer Survivors by Race, Ethnicity, and Time Since Diagnosis
por: Emerson, Marc A., et al.
Publicado: (2022)

A Novel Nomogram including AJCC Stages Could Better Predict Survival for NSCLC Patients Who Underwent Surgery: A Large Population-Based Study
por: Shang, Xiaoling, et al.
Publicado: (2020)

A hypothesized TNM staging system based on the number and location of positive lymph nodes may better reflect the prognosis for patients with NSCLC
por: Shang, Xiaoling, et al.
Publicado: (2019)

Better cancer specific survival in young small cell lung cancer patients especially with AJCC stage III
por: Wang, Haiyong, et al.
Publicado: (2017)

Association of Diagnosis of Leukodystrophy With Race and Ethnicity Among Pediatric and Adolescent Patients
por: Bonkowsky, Joshua L., et al.
Publicado: (2018)

Whole exome sequencing in Chinese mucinous pulmonary adenocarcinoma uncovers specific genetic variations different from lung adenocarcinoma
por: Zhang, Chenyue, et al.
Publicado: (2022)

Lung Cancer Screening by Race and Ethnicity in an Integrated Health System in Hawaii
por: Oshiro, Caryn E. S., et al.
Publicado: (2022)

Race and Ethnicity–Adjusted Age Recommendation for Initiating Breast Cancer Screening
por: Chen, Tianhui, et al.
Publicado: (2023)

Estrogen Receptor β1 Expression Patterns Have Different Effects on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors’ Treatment Response in Epidermal Growth Factor Receptor Mutant Lung Adenocarcinoma
por: Zhang, Lijuan, et al.
Publicado: (2021)

Construction of immune-related and prognostic lncRNA clusters and identification of their immune and genomic alterations characteristics in lung adenocarcinoma samples
por: Li, Jia, et al.
Publicado: (2020)

Associations of Socioeconomic Status, Public vs Private Insurance, and Race/Ethnicity With Metastatic Sarcoma at Diagnosis
por: Diessner, Brandon J., et al.
Publicado: (2020)

Racial and Ethnic Bias in Risk Prediction Models for Colorectal Cancer Recurrence When Race and Ethnicity Are Omitted as Predictors
por: Khor, Sara, et al.
Publicado: (2023)

Differences in Health Professionals’ Engagement With Electronic Health Records Based on Inpatient Race and Ethnicity
por: Yan, Chao, et al.
Publicado: (2023)

Methods for Using Race and Ethnicity in Prediction Models for Lung Cancer Screening Eligibility
por: Landy, Rebecca, et al.
Publicado: (2023)

Trends in Esophageal Cancer Mortality and Stage at Diagnosis by Race and Ethnicity in the United States
por: Corona, Edgar, et al.
Publicado: (2021)

Racial and Ethnic Disparity in Preoperative Chemosensitivity and Survival in Patients With Early-Stage Breast Cancer
por: Roy, Arya Mariam, et al.
Publicado: (2023)

Neighborhood Disadvantage, Race and Ethnicity, and Postpartum Depression
por: Onyewuenyi, Ticara L., et al.
Publicado: (2023)

Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015
por: Kong, Xiangyi, et al.
Publicado: (2020)

Prostate Cancer Incidence and Survival, by Stage and Race/Ethnicity — United States, 2001–2017
por: Siegel, David A., et al.
Publicado: (2020)

TERT mutations correlate with higher TMB value and unique tumor microenvironment and may be a potential biomarker for anti‐CTLA4 treatment
por: Li, Huahua, et al.
Publicado: (2020)

Male patients with TERT mutation may be more likely to benefit from immunotherapy, especially for melanoma
por: Li, Jia, et al.
Publicado: (2020)

PLNR≤20% may be a benefit from PORT for patients with IIIA-N2 NSCLC: a large population-based study
por: Shang, Xiaoling, et al.
Publicado: (2018)

Tumor Primary Location May Affect Metastasis Pattern for Patients with Stage IV NSCLC: A Population-Based Study
por: Shan, Qinge, et al.
Publicado: (2020)

Neighborhood socio-economic disadvantage and race/ethnicity as predictors of breast cancer stage at diagnosis
por: Flores, Yvonne N, et al.
Publicado: (2013)

Race/Ethnicity and Geographic Access to Urban Trauma Care
por: Tung, Elizabeth L., et al.
Publicado: (2019)

Race and Ethnicity and Primary Language in Emergency Department Triage
por: Joseph, Joshua W., et al.
Publicado: (2023)

Human Papillomavirus Awareness by Educational Level and by Race and Ethnicity
por: Stephens, Erica S., et al.
Publicado: (2023)

Association of Race and Ethnicity With Comorbidities and Survival Among Patients With COVID-19 at an Urban Medical Center in New York
por: Kabarriti, Rafi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_57enoqr72ccaonlhqf23kqhmo3